Seneca Biopharma: Streamlined rabbit Mab platform focused on treatment of autoimmune diseases. Lead program SNC005 is a fast follower to Dupixent in Asthma and Atopic Dermatitis, entering the clinic late 2020 in China and early 2021 in the US. Preclinical data indicate that SNC005 is more potent than Dupinex. Other preclinical programs target systemic lupus, asthma and COPD.
Based in...
US - Middle Atlantic
Disease Space
Public, USA
Market Cap
202 St. Andrews Court
Blue Bell, PA 19422
United States

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Top 10 Holders of Seneca Biopharma, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Armistice Capital LLC 34.44 908,572 0.54 Stakes 5/22/20
Renaissance Technologies LLC 16.85 444,623 0.26 13F 6/30/20
Sabby Capital LLC 2.21 381,487 0.23 Stakes 12/31/19
Sabby Management LLC 4.36 115,001 0.07 13F 6/30/20
The Bank of New York Co., Inc. 1.79 47,341 0.03 13F 6/30/20
Virtu Financial BD LLC 1.20 31,569 0.02 13F 6/30/20
UBS Group AG (13f Subfiler) 0.55 14,435 0.01 13F 6/30/20
Northern Trust Corp. 0.45 11,961 0.01 13F 6/30/20
HRT Financial LLC 0.44 11,631 0.01 13F 6/30/20
The Vanguard Group, Inc. 0.31 8,277 0.00 Funds 8/31/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.